FTT-30962-25797
4 vaccinations
10 coded responses
42 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 223 / VA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-10
Dose 1 — Moderna
-
2021-01-11
Registered in v-safe
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body achesAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-02-01
-
2021-02-07
Dose 2 — Moderna
- 2021-02-07
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Wheezing — Feeling: Good · Site: PainFree text: Developed wheeze/cough similar to mild bronchitis last evening.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Respiratory tract irritation, Secretion discharge — Feeling: Good · Fatigue or tirednessFree text: Lung irritation/mucous with slight coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-21
- 2021-05-09
- 2021-08-09
-
2021-12-29
Dose 3 — Moderna
-
2021-12-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-07
- 2022-01-14
-
2022-01-28
Survey response — day 28, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: FairFree text: Treatment for recurring fungal ear infection. Ongoing since August.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Survey response — day 42, dose 3MedDRA: Ear infection fungal, Ear pain, Ear pruritus — Feeling: FairFree text: Continued fungal ear infection, itching and pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Survey response — 3 months, dose 3MedDRA: Ear infection fungal — Feeling: GoodFree text: Fungal ear infection for 6+ months continues.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-29
Survey response — 6 months, dose 3MedDRA: Vitamin B12 deficiency — Feeling: GoodFree text: B12 deficiency, undergoing supplements for treatmentMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Dose 4 — Moderna
-
2022-09-13
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2022-09-17
- 2022-09-19
- 2022-10-03
- 2022-10-10
-
2022-10-17
Survey response — day 35, dose 4MedDRA: Conjunctivitis, Respiratory tract congestion, Sinus pain — Feeling: FairFree text: Conjunctivitis and sinus pain congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — day 42, dose 4MedDRA: Ear pain, Paranasal sinus discomfort, Sinus pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ongoing sinus pressure and pain. Occasional ear pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-10 | Moderna | |
| 2 | 2021-02-07 | Moderna | |
| 3 | 2021-12-29 | Moderna | No |
| 4 | 2022-09-12 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Developed wheeze/cough similar to mild bronchitis last evening.
Systemic reaction (other): Lung irritation/mucous with slight cough
Release 11 — day 28, dose 3
Symptoms: Treatment for recurring fungal ear infection. Ongoing since August.
Release 11 — day 42, dose 3
Symptoms: Continued fungal ear infection, itching and pain.
Release 11 — 3 months, dose 3
Symptoms: Fungal ear infection for 6+ months continues.
Release 12 — 6 months, dose 3
Symptoms: B12 deficiency, undergoing supplements for treatment
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness
Release 12 — day 35, dose 4
Symptoms: Conjunctivitis and sinus pain congestion
Release 12 — day 42, dose 4
Symptoms: Ongoing sinus pressure and pain. Occasional ear pain.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | Ear infection fungal | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Ear pruritus | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SD | Vitamin B12 deficiency | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Respiratory tract irritation | ✓ | ✓ | ✓ |
| SRO | Secretion discharge | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release